5 completed, 2 unknown. 7 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 5, Unknown 2 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Cardiomyopathy: new trials by email Literature Review of Cardiomyopathy trials Research Report on Cardiomyopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias Cardiac Sympathetic Denervation (CSD), Routine Care - Sudden Cardiac Death, Ventricular Tachycardia | Phase 3 | Unknown | University of California, Los Angeles | 40 | 2021-07-26 | 2024-01-19 |
| Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy Nebivolol, Placebo - Duchenne Muscular Dystrophy, Cardiomyopathy | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 51 | 2012-02-13 | 2025-11-20 |
| Clinical Outcomes Related to Cardiac Resynchronization Therapy Deactivation of Super Responders Cardiac Resynchronization Therapy Device - Cardiomyopathy | Phase 2 / Phase 3 | Completed | Yuksek Ihtisas Hospital | 19 | 2009-01-01 | 2014-09-25 |
| Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation ATI-5923, Coumadin (warfarin) - Atrial Fibrillation, Atrial Flutter | Phase 2 / Phase 3 | Unknown | ARYx Therapeutics | 600 | 2008-05-01 | 2010-02-02 |
| Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing Nitric Oxide for inhalation, Oxygen, Nitric Oxide plus Oxygen - Idiopathic Pulmonary Arterial Hypertension, Cardiomyopathy | Phase 3 | Completed | Mallinckrodt | 136 | 2004-09-01 | 2019-12-20 |
| Biventricular Pacing In Patients With Left Ventricular Dysfunction After Cardiovascular Surgery Atrial synchronous bi-ventricular pacing - Cardiomyopathy, Heart Failure, Congestive | Phase 3 | Completed | Corewell Health East | 40 | 2004-08-01 | 2011-04-05 |
| Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized Patients With Heart Failure Nesiritide - Kidney Diseases, Congestive Heart Failure | Phase 3 | Completed | Mayo Clinic | 104 | 2003-03-01 | 2009-11-16 |
Cardiomyopathies (7) · Heart Failure (4) · Acute Lung Injury (1) · Atrial Fibrillation (1) · Atrial Flutter (1) · Death, Sudden, Cardiac (1) · Familial Primary Pulmonary Hypertension (1) · Heart Defects, Congenital (1) · Kidney Diseases (1) · Muscular Dystrophy, Duchenne (1) · Myocardial Infarction (1) · Renal Insufficiency (1) · Tachycardia, Ventricular (1) · Ventricular Fibrillation (1)
Cardiovascular Diseases (7) · Heart Diseases (7) · Arrhythmias, Cardiac (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Cardiac Conduction System Disease (1) · Cardiovascular Abnormalities (1) · Congenital Abnormalities (1) · Death (1) · Death, Sudden (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genetic Diseases, Inborn (1) · Genetic Diseases, X-Linked (1)
Cardiac Resynchronization Therapy Devices (1) · Endothelium-Dependent Relaxing Factors (1) · Inhalation (1) · Natriuretic Peptide, Brain (1) · Nebivolol (1) · Nitric Oxide (1) · Oxygen (1) · Warfarin (1) · tecarfarin (1)
ARYx Therapeutics (1) · Assistance Publique - Hôpitaux de Paris (1) · Corewell Health East (1) · Mallinckrodt (1) · Mayo Clinic (1) · University of California, Los Angeles (1) · Yuksek Ihtisas Hospital (1)
United States (5) · France (2) · Netherlands (1) · Spain (1) · United Kingdom (1)
David E Haines, MD (1) · Margaret M. Redfield, M.D. (1) · Marmar Vaseghi, MD, PhD (1) · Rudolph F Evonich, MD (1) · Serkan Cay, MD (1)
2004 (1)